S. YOLBAŞ Et Al. , "Paricalcitol inhibits the Wnt/beta-catenin signaling pathway and ameliorates experimentally induced arthritis," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.5, pp.1080-1086, 2018
YOLBAŞ, S. Et Al. 2018. Paricalcitol inhibits the Wnt/beta-catenin signaling pathway and ameliorates experimentally induced arthritis. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.5 , 1080-1086.
YOLBAŞ, S., Yildirim, A., TEKTEMUR, A., ÇELİK, Z. B., Onalan Etem, E., ÖZERCAN, İ. H., ... Akin, M. M.(2018). Paricalcitol inhibits the Wnt/beta-catenin signaling pathway and ameliorates experimentally induced arthritis. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.5, 1080-1086.
YOLBAŞ, SERVET Et Al. "Paricalcitol inhibits the Wnt/beta-catenin signaling pathway and ameliorates experimentally induced arthritis," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.5, 1080-1086, 2018
YOLBAŞ, SERVET Et Al. "Paricalcitol inhibits the Wnt/beta-catenin signaling pathway and ameliorates experimentally induced arthritis." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.5, pp.1080-1086, 2018
YOLBAŞ, S. Et Al. (2018) . "Paricalcitol inhibits the Wnt/beta-catenin signaling pathway and ameliorates experimentally induced arthritis." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.5, pp.1080-1086.
@article{article, author={SERVET YOLBAŞ Et Al. }, title={Paricalcitol inhibits the Wnt/beta-catenin signaling pathway and ameliorates experimentally induced arthritis}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2018, pages={1080-1086} }